Work

Predictors of the Antidepressant Effects of Ketamine and Psychedelic Substances

Year: 2025
Type: dissertation
Abstract: Increasing clinical evidence demonstrates the efficacy of dissociative and psychedelic substances, such as ketamine and psilocybin, as interventions for treatment-resistant depression (TRD). This thesis explored optimal treatment designs for psilocybin-assisted therapy (PAT) and predictors of ketamine’s antidepressant effects using a multi-method approach. First, a meta-analysis found longer psychological support and weight-adjusted psilocybin doses were associated with greater antidepressant effects. Second, a cross-sectional survey of naturalistic ketamine consumers (n=460) found use within (n=238) and outside (n=222) clinic settings did not affect self-reported benefits. Third, a systematic review of 112 ketamine studies identified 68 predictor variables, most showing no associations with antidepressant effects. Lastly, retrospective analyses of TRD patients (n=77) receiving IV ketamine revealed early improvements after second of eight doses reliably predicted end-of-treatment response. Symptom severity, neuromodulation history, and adverse childhood experiences did not influence outcomes. These findings offer novel, actionable insights for personalized delivery of ketamine and PAT for TRD.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7132975307
Cites: 294
Cited by:
Related to: 9